19Jan, 2021
CIRCULOGENE Appoints Stephen Unger Chief Financial Officer
BIRMINGHAM, Ala. – CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine through rapid delivery of actionable results, announced today that Stephen Unger has joined the company as Chief Financial Officer. Mr. Unger has more [...]
22May, 2020
Free Webinar: Drawing NGS Plasma at Time of Lung Biopsy
CIRCULOGENE Free Webinar Drawing NGS Plasma at Time of Lung Biopsy, To Do or Not To Do Jun 3, 2020 7:00PM Eastern Time Please join us for this free educational webinar where our panel [...]
21Apr, 2020
Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology
Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology cfDNA levels correlate significantly with biomarkers of multiorgan damage in first abstract stemming from DOD research grant to [...]